Skip to main content
. 2024 Jun 20;16(6):e62775. doi: 10.7759/cureus.62775

Figure 3. Average values of Charlson Comorbidity Index (CCI) scores, general distribution, individual trend, median, quartiles, and outliers.

Figure 3

Group HF-S/V, patients undergoing treatment with sacubitril/valsartan; Group HF-CT, patients receiving conventional therapy